Yahoo · Sep 17, 2026
BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability
BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology are helping protect profitability.

NASDAQ · BTSG
Healthcare · Medical - Healthcare Information Services
$56.55
Down-$0.77 (-1.36%)
Updated Sep 23, 2026, 9:02 PM
SID Score
5.0/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
BTSG closed at $56.55 after 20 trading sessions, down 1.19% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $56.10 | $57.05 | $55.815 | $56.55 | 2.08M |
| Sep 21, 2026 | $56.79 | $56.96 | $55.35 | $55.86 | 2.66M |
| Sep 18, 2026 | $56.235 | $57.51 | $55.64 | $56.78 | 9.36M |
| Sep 17, 2026 | $59.50 | $60.00 | $56.56 | $56.60 | 2.45M |
| Sep 16, 2026 | $59.35 | $60.00 | $58.79 | $58.96 | 1.65M |
| Sep 15, 2026 | $60.30 | $60.53 | $58.275 | $58.84 | 1.43M |
| Sep 14, 2026 | $57.91 | $60.77 | $57.91 | $60.30 | 3.45M |
| Sep 11, 2026 | $59.045 | $59.90 | $58.075 | $58.73 | 2.49M |
| Sep 10, 2026 | $61.33 | $62.615 | $57.68 | $57.88 | 3.32M |
| Sep 9, 2026 | $62.575 | $62.825 | $60.925 | $61.99 | 1.3M |
| Sep 8, 2026 | $60.73 | $63.03 | $60.69 | $62.56 | 3.21M |
| Sep 4, 2026 | $60.51 | $61.75 | $60.51 | $60.73 | 1.73M |
| Sep 3, 2026 | $60.72 | $61.475 | $58.98 | $61.43 | 2.11M |
| Sep 2, 2026 | $59.16 | $60.58 | $58.97 | $60.25 | 1.77M |
| Sep 1, 2026 | $58.55 | $59.91 | $58.495 | $59.16 | 1.49M |
| Aug 31, 2026 | $58.76 | $59.07 | $57.80 | $58.40 | 1.92M |
| Aug 28, 2026 | $60.54 | $61.31 | $59.04 | $59.13 | 1.51M |
| Aug 27, 2026 | $61.42 | $63.14 | $60.53 | $60.90 | 3.22M |
| Aug 26, 2026 | $57.20 | $61.37 | $56.75 | $61.35 | 2.55M |
| Aug 25, 2026 | $59.55 | $60.18 | $56.43 | $57.23 | 2.6M |
The latest Smart Investors Daily articles mentioning BTSG.
BTSG research
Company profile and research snapshot.
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2026 | BTIG | Buy | — |
| Aug 3, 2026 | BTIG | Buy | — |
| Jul 14, 2026 | Morgan Stanley | Overweight | — |
| Jul 14, 2026 | Keybanc | Overweight | — |
| Jul 13, 2026 | Wells Fargo | Overweight | — |
No generated briefing is available yet.
Yahoo · Sep 17, 2026
BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology are helping protect profitability.
Yahoo · Sep 16, 2026
Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.
Yahoo · Sep 16, 2026
IQV's accelerating organic growth, robust R&DS bookings and expanding AI adoption are strengthening demand visibility and business momentum.
SeekingAlpha · Sep 16, 2026
BrightSpring Health Services, Inc. (BTSG) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 3:20 PM EDTCompany ParticipantsJennifer...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BTSG.